Heart Valves Companies
Heart valves are crucial components of the cardiovascular system, responsible for ensuring the unidirectional flow of blood through the heart. When these valves malfunction, it can lead to serious health issues.
Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Â
Latest Heart Valves Companies Update:
Edwards Lifesciences Received FDA approval for the first-ever transcatheter mitral valve replacement (TMVR) system with a self-expanding anchor, potentially expanding treatment options for patients with mitral valve regurgitation. Announced positive initial results from its PARTNER 3 IDE clinical trial, demonstrating the safety and efficacy of its third-generation transcatheter aortic valve (TAVR) system.
Abbott Launched its newest transcatheter aortic valve (TAVR) system, offering improved delivery and positioning features for surgeons. Entered into a strategic partnership with Medtronic to develop and commercialize new heart valve technologies.
Medtronic Received FDA approval for its Hugo™ robotic surgery platform, designed for use in minimally invasive procedures like heart valve surgeries, potentially expanding market reach. Announced the expansion of its CoreValve Evolut transcatheter aortic valve (TAVR) system family with the introduction of a new low-profile valve option.
Boston Scientific Received CE Mark approval for its Lotus Edge™, a next-generation transcatheter aortic valve (TAVR) system with a unique anchor design, targeting specific patient anatomies. Expanded its presence in the tricuspid valve replacement market with the acquisition of Claret Medical, further diversifying its portfolio.
List of Heart Valves Key companies in the market
- Edwards Lifesciences Corporation
- Abbott
- Medtronic
- LivaNova PLC
- Boston Scientific Corporation
- CryoLife, Inc.
- Micro Interventional Devices, Inc.
Heart Valves Market Highlights:
Heart Valves Market Highlights:
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
